ViroPharma Denied Block On Generic Vancocin Approval

Law360, New York (January 09, 2013, 5:54 PM ET) -- A Washington federal judge on Wednesday ended ViroPharma Inc.'s bid to cancel the U.S. Food and Drug Administration's approval of generic versions of antibiotic Vancocin and extend its exclusive rights to the drug, saying the FDA had acted properly in approving the generics.

According to U.S. District Judge Ellen Segal Huvelle's order, denying ViroPharma's motion for summary judgment and granting the FDA's motion to dismiss the case, the FDA was well within its discretion to approve generic versions of the drug and deny the drugmaker an...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

VIROPHARMA INCORPORATED v. HAMBURG et al


Case Number

1:12-cv-00584

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

Ellen S. Huvelle

Date Filed

April 13, 2012

Law Firms

Companies

Government Agencies